Of the 5 PDC cell lines, four METex14del+ cell lines were tested for potential anti-tumor efficacy of c-MET inhibitors, crizotinib (small molecule) and SAIT301 (monoclonal antibody) [6]. This evidence concerns the gene MET and neoplasm.